Individualized Graves' disease remission rates conversations: a videographic analysis of medical encounters
Endocrine
.
2022 Apr;76(1):237-239.
doi: 10.1007/s12020-022-02989-x.
Epub 2022 Feb 1.
Authors
Jessica Hidalgo
1
,
Sebastián Vallejo
2
,
Omar M El Kawkgi
1
3
4
,
Naykky M Singh Ospina
5
,
Spyridoula Maraka
1
6
7
,
Juan P Brito
8
Affiliations
1
Knowledge and Evaluation Research Unit in Endocrinology, Mayo Clinic, Rochester, MN, USA.
2
University of Miami/Jackson Memorial Hospital, Miami, FL, USA.
3
Division of Endocrinology, Diabetes & Nutrition, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
4
Department of Endocrinology, Mayo Clinic Health System, Eau Claire, WI, USA.
5
Division of Endocrinology, Department of Medicine, University of Florida, Gainesville, FL, USA.
6
Division of Endocrinology and Metabolism, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
7
Medicine Service, Central Arkansas Veterans Healthcare System, Little Rock, AR, USA.
8
Division of Endocrinology, Diabetes & Nutrition, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
[email protected]
.
PMID:
35103895
PMCID:
PMC10292114
DOI:
10.1007/s12020-022-02989-x
No abstract available
Publication types
Letter
MeSH terms
Antithyroid Agents
Graves Disease* / therapy
Humans
Substances
Antithyroid Agents
Grants and funding
K08 CA248972/CA/NCI NIH HHS/United States